BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,512 | -5.1% | 40,058 | +14.6% | 0.01% | 0.0% |
| Q2 2023 | $1,593 | +17.4% | 34,963 | +4.5% | 0.01% | 0.0% |
| Q1 2023 | $1,357 | -14.6% | 33,451 | +7.3% | 0.01% | -12.5% |
| Q4 2022 | $1,589 | -99.9% | 31,183 | -0.6% | 0.01% | -20.0% |
| Q3 2022 | $1,689,000 | -16.0% | 31,356 | +0.2% | 0.01% | -9.1% |
| Q2 2022 | $2,010,000 | -12.3% | 31,300 | +5.9% | 0.01% | 0.0% |
| Q1 2022 | $2,293,000 | -22.7% | 29,570 | -14.5% | 0.01% | -15.4% |
| Q4 2021 | $2,968,000 | +29.6% | 34,575 | +21.4% | 0.01% | +18.2% |
| Q3 2021 | $2,291,000 | -5.7% | 28,486 | -5.6% | 0.01% | -8.3% |
| Q2 2021 | $2,429,000 | -6.3% | 30,173 | -1.8% | 0.01% | -14.3% |
| Q1 2021 | $2,592,000 | +37.0% | 30,734 | +30.3% | 0.01% | +27.3% |
| Q4 2020 | $1,892,000 | -0.1% | 23,582 | +0.2% | 0.01% | -15.4% |
| Q3 2020 | $1,893,000 | -7.2% | 23,536 | -0.7% | 0.01% | -13.3% |
| Q2 2020 | $2,040,000 | +10.4% | 23,694 | +4.1% | 0.02% | -16.7% |
| Q1 2020 | $1,848,000 | -8.7% | 22,765 | -6.0% | 0.02% | +12.5% |
| Q4 2019 | $2,025,000 | -5.5% | 24,219 | -1.1% | 0.02% | -15.8% |
| Q3 2019 | $2,142,000 | +4.2% | 24,490 | -2.4% | 0.02% | 0.0% |
| Q2 2019 | $2,055,000 | -0.2% | 25,088 | -1.0% | 0.02% | -5.0% |
| Q1 2019 | $2,060,000 | +34.3% | 25,334 | +8.7% | 0.02% | +17.6% |
| Q4 2018 | $1,534,000 | -19.1% | 23,309 | -5.3% | 0.02% | -5.6% |
| Q3 2018 | $1,897,000 | +9.3% | 24,612 | +4.7% | 0.02% | 0.0% |
| Q2 2018 | $1,736,000 | +16.4% | 23,506 | +2.4% | 0.02% | +5.9% |
| Q1 2018 | $1,492,000 | -0.3% | 22,947 | -0.9% | 0.02% | -5.6% |
| Q4 2017 | $1,497,000 | -26.0% | 23,161 | -28.1% | 0.02% | -33.3% |
| Q3 2017 | $2,023,000 | +0.3% | 32,232 | -3.2% | 0.03% | -10.0% |
| Q2 2017 | $2,016,000 | -30.1% | 33,294 | -45.1% | 0.03% | -44.4% |
| Q3 2016 | $2,885,000 | +105.5% | 60,610 | +77.3% | 0.05% | +68.8% |
| Q1 2016 | $1,404,000 | +3.9% | 34,188 | -3.5% | 0.03% | 0.0% |
| Q4 2015 | $1,351,000 | -57.6% | 35,422 | -22.2% | 0.03% | -63.6% |
| Q2 2015 | $3,184,000 | +10.8% | 45,529 | +8.6% | 0.09% | +7.3% |
| Q1 2015 | $2,873,000 | +41.2% | 41,936 | +51.1% | 0.08% | +30.2% |
| Q4 2014 | $2,034,000 | -13.8% | 27,747 | -15.6% | 0.06% | -10.0% |
| Q3 2014 | $2,360,000 | -2.2% | 32,888 | -1.5% | 0.07% | -16.7% |
| Q2 2014 | $2,414,000 | +36.5% | 33,385 | +38.9% | 0.08% | +25.4% |
| Q1 2014 | $1,768,000 | +14.6% | 24,028 | +8.3% | 0.07% | +6.3% |
| Q4 2013 | $1,543,000 | +15.2% | 22,191 | +8.9% | 0.06% | +6.8% |
| Q3 2013 | $1,339,000 | +0.7% | 20,381 | +6.2% | 0.06% | -13.2% |
| Q2 2013 | $1,330,000 | – | 19,197 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |